Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

• Paul Nankivell,
• Piers Gaunt,
• Claire Gaunt,
• Julia Sissons,
• Evaggelia Liaskou,
• Yolande Jefferson,
• Tessa Fulton-Lieuw,
• Saloni Mittal,
• Hisham Mehanna,
• PETNECK2 Research Team

Affiliations

Paul Nankivell

Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham

Piers Gaunt

Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham

Claire Gaunt

Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham

Julia Sissons

Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham

Evaggelia Liaskou

Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham

Yolande Jefferson

Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham

Tessa Fulton-Lieuw

Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham

Saloni Mittal

Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham

Hisham Mehanna

Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham

PETNECK2 Research Team